{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:01:53Z","timestamp":1791925313135,"version":"4.3.4"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Kidney cancer is one of the most common urological cancers worldwide, and kidney renal clear cell cancer (KIRC) is the major histologic subtype. Our previous study found that von-Hippel Lindau (VHL) gene mutation, the dominant reason for sporadic KIRC and hereditary kidney cancer-VHL syndrome, could affect VHL disease-related cancers development by inducing telomere shortening. However, the prognosis role of telomere-related genes in kidney cancer has not been well discussed. In this study, we obtained the telomere-related genes (TRGs) from TelNet. We obtained the clinical information and TRGs expression status of kidney cancer patients in The Cancer Genome Atlas (TCGA) database, The International Cancer Genome Consortium (ICGC) database, and the Clinical Proteomic Tumor Analysis Consortium (CPTAC) database. Totally 353 TRGs were differential between tumor and normal tissues in the TCGA-KIRC dataset. The total TCGA cohort was divided into discovery and validation TCGA cohorts and then using univariate cox regression, lasso regression, and multivariate cox regression method to conduct data analysis sequentially, ten TRGs (ISG15, RFC2, TRIM15, NEK6, PRKCQ, ATP1A1, ELOVL3, TUBB2B, PLCL1, NR1H3) risk model had been constructed finally. The kidney patients in the high TRGs risk group represented a worse outcome in the discovery TCGA cohort (p&amp;lt;0.001), and the result was validated by these four cohorts (validation TCGA cohort, total TCGA cohort, ICGC cohort, and CPTAC cohort). In addition, the TRGs risk score is an independent risk factor for kidney cancer in all these five cohorts. And the high TRGs risk group correlated with worse immune subtypes and higher tumor mutation burden in cancer tissues. In addition, the high TRGs risk group might benefit from receiving immune checkpoint inhibitors and targeted therapy agents. Moreover, the proteins NEK6, RF2, and ISG15 were upregulated in tumors both at the RNA and protein levels, while PLCL1 and PRKCQ were downregulated. The other five genes may display the contrary expression status at the RNA and protein levels. In conclusion, we have constructed a telomere-related genes risk model for predicting the outcomes of kidney cancer patients, and the model may be helpful in selecting treatment agents for kidney cancer patients.<\/jats:p>","DOI":"10.3389\/fimmu.2022.975057","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T07:59:59Z","timestamp":1663315199000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Telomere-related gene risk model for prognosis and drug treatment efficiency prediction in kidney cancer"],"prefix":"10.3389","volume":"13","author":[{"given":"Song-Chao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-Kui","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-hui","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S0140-6736(15)00046-X","article-title":"Renal cancer","volume":"387","author":"Capitanio","year":"2016","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.11.033","article-title":"External validation of the Mayo clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology","volume":"57","author":"Zigeuner","year":"2010","journal-title":"Eur Urol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70559-4","article-title":"External validation and comparison with other models of the international metastatic renal-cell carcinoma database consortium prognostic model: a population-based study","volume":"14","author":"Heng","year":"2013","journal-title":"Lancet Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.1.289","article-title":"Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma","volume":"20","author":"Motzer","year":"2002","journal-title":"J Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.05.111","article-title":"Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma","volume":"20","author":"Zisman","year":"2002","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.806264","article-title":"Identification of a hypoxia-related gene model for predicting the prognosis and formulating the treatment strategies in kidney renal clear cell carcinoma","volume":"11","author":"Ning","year":"2021","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.818984","article-title":"Construction of a lactate-related prognostic signature for predicting prognosis, tumor microenvironment, and immune response in kidney renal clear cell carcinoma","volume":"13","author":"Sun","year":"2022","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41576-019-0099-1","article-title":"Telomeres and telomerase: three decades of progress","volume":"20","author":"Shay","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.12688\/f1000research.14068.1","article-title":"Beginning at the ends: telomeres and human disease","volume":"7","author":"Savage","year":"2018","journal-title":"F1000Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2016.171","article-title":"Telomeres in cancer: tumour suppression and genome instability","volume":"18","author":"Maciejowski","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-0024","article-title":"Telomere shortening is associated with genetic anticipation in Chinese Von hippel-lindau disease families","volume":"74","author":"Ning","year":"2014","journal-title":"Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1055-9965.EPI-16-0343","article-title":"Telomere length and breast cancer prognosis: A systematic review","volume":"26","author":"Ennour-Idrissi","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133174","article-title":"The association between telomere length and cancer prognosis: Evidence from a meta-analysis","volume":"10","author":"Zhang","year":"2015","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S211225","article-title":"Telomere length in renal cell carcinoma: The Jekyll and Hyde biomarker of ageing of the kidney","volume":"12","author":"Morais","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.237","article-title":"Leukocyte telomere length and renal cell carcinoma survival in two studies","volume":"117","author":"Callahan","year":"2017","journal-title":"Br J Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12863-018-0617-8","article-title":"TelNet - a database for human and yeast genes involved in telomere maintenance","volume":"19","author":"Braun","year":"2018","journal-title":"BMC Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an r package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B21","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an r package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr1013","article-title":"PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update","volume":"40","author":"Wang","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12859-019-3059-z","article-title":"HPAanalyze: an r package that facilitates the retrieval and analysis of the human protein atlas data","volume":"20","author":"Tran","year":"2019","journal-title":"BMC Bioinf"},{"key":"B28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.12935","article-title":"Primary aldosteronism","volume":"74","author":"Funder","year":"2019","journal-title":"Hypertension"},{"key":"B30","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1038\/s41467-022-30638-4","article-title":"Homophilic ATP1A1 binding induces activin a secretion to promote EMT of tumor cells and myofibroblast activation","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw266","article-title":"Promoter CpG island methylation in ion transport mechanisms and associated dietary intakes jointly influence the risk of clear-cell renal cell cancer","volume":"46","author":"Deckers","year":"2017","journal-title":"Int J Epidemiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41065-021-00179-9","article-title":"Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma","volume":"158","author":"Ji","year":"2021","journal-title":"Hereditas"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1038\/s41598-022-06197-5","article-title":"RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas","volume":"12","author":"Zhao","year":"2022","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"166213","DOI":"10.1016\/j.bbadis.2021.166213","article-title":"TRIM15 promotes the invasion and metastasis of pancreatic cancer cells by mediating APOA1 ubiquitination and degradation","volume":"1867","author":"Sun","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12964-022-00875-7","article-title":"E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway","volume":"20","author":"Liang","year":"2022","journal-title":"Cell Commun Signal"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-021-00732-8","article-title":"TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination","volume":"23","author":"Zhu","year":"2021","journal-title":"Nat Cell Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000001158","article-title":"miR-141-3p suppresses development of clear cell renal cell carcinoma by regulating NEK6","volume":"33","author":"Liu","year":"2022","journal-title":"Anticancer Drugs"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2018.07.030","article-title":"Overexpression of NIMA-related kinase 6 (NEK6) contributes to malignant growth and dismal prognosis in human breast cancer","volume":"214","author":"He","year":"2018","journal-title":"Pathol Res Pract"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0455","article-title":"Castration resistance in prostate cancer is mediated by the kinase NEK6","volume":"77","author":"Choudhury","year":"2017","journal-title":"Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2013.02.012","article-title":"The inhibition of Nek6 function sensitizes human cancer cells to premature senescence upon serum reduction or anticancer drug treatment","volume":"335","author":"Jee","year":"2013","journal-title":"Cancer Lett"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/biom11020221","article-title":"The emerging function of PKCtheta in cancer","volume":"11","author":"Nicolle","year":"2021","journal-title":"Biomolecules"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2007.04.009","article-title":"Protein kinase c theta (PKCtheta): a key player in T cell life and death","volume":"55","author":"Hayashi","year":"2007","journal-title":"Pharmacol Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1042\/BST20140207","article-title":"Targeting PKCtheta in skeletal muscle and muscle diseases: good or bad","volume":"42","author":"Marrocco","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"B45","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3390\/cells11030538","article-title":"ISG15 and ISGylation in human diseases","volume":"11","author":"Mirzalieva","year":"2022","journal-title":"Cells"},{"key":"B46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.it.2016.11.001","article-title":"ISG15: In sickness and in health","volume":"38","author":"Hermann","year":"2017","journal-title":"Trends Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.canlet.2018.09.007","article-title":"ISG15 in cancer: Beyond ubiquitin-like protein","volume":"438","author":"Han","year":"2018","journal-title":"Cancer Lett"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-011-1002-x","article-title":"Targeting tumor vasculature with novel listeria-based vaccines directed against CD105","volume":"60","author":"Wood","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M511588200","article-title":"ELOVL3 is an important component for early onset of lipid recruitment in brown adipose tissue","volume":"281","author":"Westerberg","year":"2006","journal-title":"J Biol Chem"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M600230-JLR200","article-title":"Elovl3: a model gene to dissect homeostatic links between the circadian clock and nutritional status","volume":"47","author":"Anzulovich","year":"2006","journal-title":"J Lipid Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.666199","article-title":"Prognostic implication of a novel metabolism-related gene signature in hepatocellular carcinoma","volume":"11","author":"Yuan","year":"2021","journal-title":"Front Oncol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s41065-020-00152-y","article-title":"A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma","volume":"157","author":"Chen","year":"2020","journal-title":"Hereditas"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1801862","DOI":"10.1002\/advs.201801862","article-title":"Tumor cell \"Slimming\" regulates tumor progression through PLCL1\/UCP1-mediated lipid browning","volume":"6","author":"Xiong","year":"2019","journal-title":"Adv Sci (Weinh)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30204","article-title":"The roles of liver X receptor alpha in inflammation and inflammation-associated diseases","volume":"236","author":"Zhao","year":"2021","journal-title":"J Cell Physiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41419-019-1345-3","article-title":"LXRalpha promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma","volume":"10","author":"Wang","year":"2019","journal-title":"Cell Death Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/JHC.S296438","article-title":"Gene expression profile and prognostic value of m6A RNA methylation regulators in hepatocellular carcinoma","volume":"8","author":"Chang","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v12.i8.857","article-title":"Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer","volume":"12","author":"Qiu","year":"2020","journal-title":"World J Gastrointest Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.975057\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T08:00:11Z","timestamp":1663315211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.975057\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2022.975057"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.975057","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"article-number":"975057"}}